基于免疫信息学技术的雏沙门菌多表位疫苗构建OACSTPCD
Construction of a Multi-epitope Vaccine Against Salmonella Pullorum by Immunoinformatics Approach
[目的]设计针对雏沙门菌(Salmonella Pullorum)IpaJ蛋白的多表位疫苗(multi-epitope vaccine,MEV),为净化鸡白痢提供新的疫苗.[方法]选用IEDB预测雏沙门菌IpaJ蛋白的T淋巴细胞主要组织相容性复合体Ⅰ(MHCⅠ)类分子结合表位;用NetMHCⅡpan 4.0 Server预测T淋巴细胞MHC Ⅱ类分子结合表位;用IEDB预测B淋巴细胞表位.将各个服务器预测结果筛选出的表位经过VaxiJen v 2.0评估抗原性后,将合格的表位通过柔性linker串联成多表位疫苗.对构建的多表位疫苗进行抗原性、理化性质、N-糖基化位点、二级结构和三级结构预测.使用分子对接评估多表位疫苗与免疫受体的结合能力,使用免疫模拟评估多表位疫苗的免疫效果,最后优化密码子便于克隆表达.[结果]经筛选后,选择4个MHC Ⅰ、4个MHC Ⅱ和8个B淋巴细胞表位优势表位构建的多表位疫苗MEV-IpaJ.多表位疫苗MEV-IpaJ的分子质量为28.18 ku,为稳定亲水蛋白,具有良好的抗原性,存在4个潜在的N-糖基化位点,a-螺旋、延长链、β-转角和无规则卷曲分别占20.38%、19.23%、8.08%和52.31%.三级结构Ramachandran作图显示,优势区域中含有残基数占89.9%%,进行细化后优势区域的残基数增加到94.0%,三级结构突出表位作图也证明MEV-IpaJ具有良好的免疫原性.分子对接结果显示,MEV-IpaJ与Toll样受体2(Toll-like receptor 2,TLR2)和TLR4蛋白分子可对接.免疫模拟结果显示,MEV-IpaJ具有较好的免疫应答,能提高部分细胞因子的表达,经密码子优化确保设计的MEV-IpaJ可在大肠杆菌K12表达系统中高效、稳定地表达.[结论]本研究构建的多表位疫苗MEV-IpaJ可有效表达并可能诱导强烈的T细胞和B细胞免疫应答.本研究为雏沙门菌多表位疫苗的设计提供了一种新的方法,为雏沙门菌多表位疫苗的研发提供了理论依据及数据支持.
[Objective]This study was aimed to design multi-epitope vaccine against IpaJ protein of Salmonella Pullorum and provide a new vaccine for purifying chicken dysentery.[Method]In this study,IEDB was used to predict the major histocompatibility complex class Ⅰ(MHC Ⅰ)molecular binding epitopes of Salmonella Pullorum IpaJ protein in T lymphocytes.NetMHCIIpan 4.0 Server was used to predict T lymphocytes MHC Ⅱ molecular binding epitopes.B lymphocyte epitope was predicted by IEDB.After the antigenicity of the selected epitopes was evaluated by VaxiJen v 2.0,the qualified epitopes were concatenated into multi-epitope vaccine by flexible linker.Antigenicity,physicochemical properties,N-glycosylation sites,secondary structure and tertiary structure of the constructed multi-epitope vaccine were predicted.Molecular docking was used to evaluate the binding ability of the multi-epitope vaccine to the immune receptor.Immune simulation was used to evaluate the immune effect of the multi-epitope vaccine.Finally,the codon was optimized for cloning expression.[Result]After screening,the constructed multi-epitope vaccine MEV-IpaJ contained 4 MHC Ⅰ,4 MHC Ⅱ and 8 B lymphocyte epitope dominance.The relative molecular weight of the multi-epitope vaccine MEV-IpaJ was 28.18 ku,which was a stable hydrophilic protein and had good antigenicity.There were four potential N-glycoylation sites,including a-helix,extended strand,beta turn and random coil accounted for 20.38%,19.23%,8.08%and 52.31%,respectively.Ramachandran mapping of tertiary structure showed that the dominant region contained 89.9%of the residual base,and the residual base of the dominant region increased to 94.0%after refinement.The mapping of tertiary structure prominent epitope also proved that the multi-epitope vaccine had good immunogenicity,and molecular docking showed that the MEV-IpaJ could dock with Toll-like receptor 2(TLR2)and TLR4 protein molecules.The results of immune simulation showed that the MEV-IpaJ had a good immune response and could improve the expression of some cytokines.Codon optimization ensured the efficient and stable expression of the MEV-IpaJ in E.coli K12 expression system.[Conclusion]The constructed multi-epitope vaccine MEV-IpaJ could be effectively expressed and might induce strong T cell and B cell immune responses.This study provided a new method for the design of multi-epitope vaccine of Salmonella Pullorum,and provided theoretical basis and data support for the research and development of multi-epitope vaccine of Salmonella Pullorum.
谭菊;王永娟;郭广富;赵长菁;夏爱鸿;李巨银;吴敏秋;王宇航;覃秋苹
江苏农牧科技职业学院,泰州 225300
畜牧业
雏沙门菌免疫信息学表位多表位疫苗
Salmonella Pullorumimmunoinformaticsepitopemulti-epitope vaccine
《中国畜牧兽医》 2024 (001)
312-322 / 11
江苏省第六期"333高层次人才培养工程"((2022)3-23-076);江苏省现代农业职业教育行业指导委员会课题(nyhzwz202203);"家禽疾病监测及综合性防控"科技服务团队项目(NSF2022TF05);江苏农牧科技职业学院校级科研项目(NSF2023CB03)
评论